TSVT News and Press, 2seventy bio Inc. From 04/17/23

U.S. FDA accepted Bristol Myers Squibb and 2seventy bio’s supplemental Biologics License Application and has assigned a target action date of December 16, 2023 European Medicines Agency has validated Bristol Myers Squibb’s Type II variation application for Abecma ...

2023-04-10 08:26:10 ET Summary GSK's dividend yield is 3.58%, slightly higher than Bristol-Myers Squibb's 3.22%. Bristol-Myers Squibb's total debt was about $40.8 billion at the end of 2022, down $4.78 billion from the previous year, thanks to the successful integration of Celgene...

2023-03-16 16:42:16 ET 2seventy bio press release ( NASDAQ: TSVT ): Q4 GAAP EPS of -$0.60 beats by $0.96 . Revenue of $56.18M (+250.5% Y/Y) beats by $40.91M . For further details see: 2seventy bio GAAP EPS of -$0.60 beats by $0.96, revenue of $56.18M beat...

Abecma (idecabtagene vicleucel) generated $ 94M U.S. commercial revenue in 4Q 2022, $297M in FY 2022; anticipate $470-$570M U.S. revenue in 2023 Positive data from Phase 3 KarMMa-3 study published in New England Journal of Medicine Ended 2022 with $268M cash, cash equivalent...

2023-03-09 08:45:09 ET Summary 2seventy Bio's strong focus on cell therapy-based combinations for solid tumors positions them as a potential leader in the immuno-oncology market. Recent positive results from the KarMMa-3 study demonstrate the potential of the company's first-in-cl...

2seventy bio, Inc. (Nasdaq: TSVT) today announced the appointment of Wei Lin, M.D. to the company’s Board of Directors, effective immediately. “We are thrilled to welcome Dr. Wei Lin to 2seventy’s Board during an exciting time in our Company’s growth,” sai...

2seventy bio, Inc . (Nasdaq: TSVT) announced today that members of the management team will present at the 43rd Annual TD Cowen Health Care Conference at the Boston Marriott Copley Place in Boston, MA on March 7, 2023 at 10:30am ET. A live webcast will be available via the Investors and Med...

Gainers: Reata Pharmaceuticals ( RETA ) +176% . OncoSec Medical ( ONCS ) +118% . Sarepta Therapeutics ( SRPT ) +24% . PetIQ ( PETQ ) +17% . Amphastar Pharmaceuticals ( AMPH ) +15% . Losers: Novavax ( NVAX ) -24% . ...

Marengo Therapeutics Appoints Kevin Chin, MD, MS as Chief Medical Officer PR Newswire CAMBRIDGE, Mass. , March 1, 2023 /PRNewswire/ -- Marengo Therapeutics, Inc., a company pioneering novel immuno-therapeutics targeting the T cell receptor (TCR) Vβ&#x...

Performance Shipping ( PSHG ) -43% . Novavax ( NVAX ) -28% on Q4 earnings release . Tupperware Brands TUP -25% after posting preliminary results . First Horizon ( FHN ) -23% as TD says it won't receive regulatory OK in time for May close . M...